92 related articles for article (PubMed ID: 16085415)
1. Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesis.
Brands M; Ergüden JK; Hashimoto K; Heimbach D; Schröder C; Siegel S; Stasch JP; Weigand S
Bioorg Med Chem Lett; 2005 Oct; 15(19):4201-5. PubMed ID: 16085415
[TBL] [Abstract][Full Text] [Related]
2. Selective indole-based ECE inhibitors: synthesis and pharmacological evaluation.
Brands M; Ergüden JK; Hashimoto K; Heimbach D; Krahn T; Schröder C; Siegel S; Stasch JP; Tsujishita H; Weigand S; Yoshida NH
ChemMedChem; 2006 Jan; 1(1):96-105. PubMed ID: 16892341
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors.
Firooznia F; Gude C; Chan K; Fink CA; Qiao Y; Satoh Y; Marcopoulos N; Savage P; Beil ME; Bruseo CW; Trapani AJ; Jeng AY
Bioorg Med Chem Lett; 2001 Feb; 11(3):375-8. PubMed ID: 11212114
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1.
Fink CA; Moskal M; Firooznia F; Hoyer D; Symonsbergen D; Wei D; Qiao Y; Savage P; Beil ME; Trapani AJ; Jeng AY
Bioorg Med Chem Lett; 2000 Sep; 10(17):2037-9. PubMed ID: 10987444
[TBL] [Abstract][Full Text] [Related]
5. Targeting ACE and ECE with dual acting inhibitors.
Hanessian S; Guesné S; Riber L; Marin J; Benoist A; Mennecier P; Rupin A; Verbeuren TJ; De Nanteuil G
Bioorg Med Chem Lett; 2008 Feb; 18(3):1058-62. PubMed ID: 18160283
[TBL] [Abstract][Full Text] [Related]
6. In-silico characterization of ECE-1 inhibitors.
Ajay Babu P; Colluru VT; Anaparthy N
Comput Biol Med; 2012 Apr; 42(4):446-57. PubMed ID: 22245098
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of triazole-Tethered pyrrolidine libraries: novel ECE inhibitors.
Kitas EA; Löffler BM; Daetwyler S; Dehmlow H; Aebi JD
Bioorg Med Chem Lett; 2002 Jul; 12(13):1727-30. PubMed ID: 12067547
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel substituted pyridines as inhibitors of endothelin converting enzyme-1 (ECE-1).
Massa MA; Patt WC; Ahn K; Sisneros AM; Herman SB; Doherty A
Bioorg Med Chem Lett; 1998 Aug; 8(16):2117-22. PubMed ID: 9873497
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
Wallace EM; Moliterni JA; Moskal MA; Neubert AD; Marcopulos N; Stamford LB; Trapani AJ; Savage P; Chou M; Jeng AY
J Med Chem; 1998 Apr; 41(9):1513-23. PubMed ID: 9554884
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of diversely substituted azacyclic inhibitors of endothelin converting enzyme.
Hanessian S; Gauchet C; Charron G; Marin J; Nakache P
J Org Chem; 2006 Mar; 71(7):2760-78. PubMed ID: 16555831
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.
Lin CL; Winardi W; Jeng AY; Kwan AL
Neurol Res; 2006 Oct; 28(7):721-9. PubMed ID: 17164035
[TBL] [Abstract][Full Text] [Related]
12. Daleformis, a new phytoalexin from the roots fo Dalea filiciformis: an inhibitor of endothelin converting enzyme.
Patil AD; Freyer AJ; Eggleston DS; Haltiwanger RC; Tomcowicz B; Breen A; Johnson RK
J Nat Prod; 1997 Mar; 60(3):306-8. PubMed ID: 9157193
[TBL] [Abstract][Full Text] [Related]
13. A rapid and selective endothelin-converting enzyme assay: characterization of a phosphoramidon-sensitive enzyme from guinea pig lung membrane.
Fawzi AB; Cleven RM; Wright DL
Anal Biochem; 1994 Nov; 222(2):342-50. PubMed ID: 7864357
[TBL] [Abstract][Full Text] [Related]
14. Novel selective quinazoline inhibitors of endothelin converting enzyme-1.
Ahn K; Sisneros AM; Herman SB; Pan SM; Hupe D; Lee C; Nikam S; Cheng XM; Doherty AM; Schroeder RL; Haleen SJ; Kaw S; Emoto N; Yanagisawa M
Biochem Biophys Res Commun; 1998 Feb; 243(1):184-90. PubMed ID: 9473502
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells.
Berger Y; Dehmlow H; Blum-Kaelin D; Kitas EA; Löffler BM; Aebi JD; Juillerat-Jeanneret L
J Med Chem; 2005 Jan; 48(2):483-98. PubMed ID: 15658862
[TBL] [Abstract][Full Text] [Related]
16. CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
Jeng AY; Savage P; Beil ME; Bruseo CW; Hoyer D; Fink CA; Trapani AJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():98S-101S. PubMed ID: 12193064
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.
Scheiper B; Matter H; Steinhagen H; Stilz U; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2010 Nov; 20(21):6268-72. PubMed ID: 20850300
[TBL] [Abstract][Full Text] [Related]
18. TMC-66, a new endothelin converting enzyme inhibitor produced by Streptomyces sp. A5008.
Asai Y; Nonaka N; Suzuki S; Nishio M; Takahashi K; Shima H; Ohmori K; Ohnuki T; Komatsubara S
J Antibiot (Tokyo); 1999 Jul; 52(7):607-12. PubMed ID: 10513839
[TBL] [Abstract][Full Text] [Related]
19. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
20. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
